Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mult Scler Relat Disord. 2018 Jul 12;25:29–36. doi: 10.1016/j.msard.2018.06.007

Table 2.

Lesion and brain volume measures in patients and CTRLs.

AAs CAs CTRLs pa pb pc
T2 LV (mL) 3.60 ± 3.91 3.03 ± 2.44 - - - 0.508
T1 LV (mL) 0.57 ± 0.43 0.52 ± 0.62 - - - 0.743
CLs (n) 8.79 ± 6.53 6.60 ± 4.68 - - - 0.149
CL-V (mL) 0.33 ± 0.28 0.22 ± 0.18 - - 0.072
NBV (mL) 1511.37 ± 110.49 1485.35 ± 75.52 1499.14 ± 84.00 0.977 0.591 0.357
NWMV (mL) 706.06 ± 56.94 693.14 ± 33.70 703.09 ± 52.67 0.961 0.497 0.399
NGMV (mL) 805.31 ± 56.05 792.21 ± 41.37 796.04 ± 44.06 0.910 0.796 0.354

Abbreviations: AAs=African Americans; CA=Caucasians; CL=cortical lesions; CL-V=cortical lesions volume; LV=lesion volume; NBV=normalized brain volume; NWMV=normalized white matter volume; NGMV=normalized grey matter volume.

a

ANOVA age and gender corrected (AAs vs CTRLs; p<0.05).

b

ANOVA age and gender corrected (CAs vs CTRLs; p<0.05).

c

ANOVA age and gender corrected (AAs vs CAs; p<0.05).

All the values are expressed as mean ± SD.